Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonie Beyer

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Neuroinflammation|December 15, 2020
Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseasesGloria Biechele, Nicolai Franzmeier, Tanja Blume, et al.
Frontiers in Aging Neuroscience|May 31, 2021
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal SyndromeJulia Schmitt, Carla Palleis, Julia Sauerbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer DiseaseGloria Biechele, Laura Sebastian Monasor, Karin Wind, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse ModelChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Neuroimage|July 28, 2024
Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparisonJohannes Gnörich, Mara Koehler, Karin Wind-Mark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP MiceCarola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse ModelsChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumoursLeonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Neuroinflammation|December 15, 2020
Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseasesGloria Biechele, Nicolai Franzmeier, Tanja Blume, et al.
Frontiers in Aging Neuroscience|May 31, 2021
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal SyndromeJulia Schmitt, Carla Palleis, Julia Sauerbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer DiseaseGloria Biechele, Laura Sebastian Monasor, Karin Wind, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse ModelChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2022
Feasibility of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinomaLena M Unterrainer, Simon Lindner, Lennert Eismann, et al.
Neuroimage|July 28, 2024
Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparisonJohannes Gnörich, Mara Koehler, Karin Wind-Mark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP MiceCarola Focke, Tanja Blume, Benedikt Zott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2020
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse ModelsChristian Sacher, Tanja Blume, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumoursLeonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Pageof 8